KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT (2016 - 2025)

Historic EBT for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $142.8 million.

  • Medpace Holdings' EBT rose 2025.66% to $142.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $519.4 million, marking a year-over-year increase of 2002.99%. This contributed to the annual value of $475.9 million for FY2024, which is 4177.76% up from last year.
  • Medpace Holdings' EBT amounted to $142.8 million in Q3 2025, which was up 2025.66% from $124.5 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' EBT ranged from a high of $142.8 million in Q3 2025 and a low of $42.7 million during Q2 2021
  • For the 5-year period, Medpace Holdings' EBT averaged around $88.5 million, with its median value being $83.2 million (2023).
  • Its EBT has fluctuated over the past 5 years, first soared by 4961.27% in 2022, then soared by 159.84% in 2023.
  • Medpace Holdings' EBT (Quarter) stood at $55.9 million in 2021, then surged by 31.69% to $73.6 million in 2022, then rose by 23.17% to $90.7 million in 2023, then skyrocketed by 47.6% to $133.9 million in 2024, then rose by 6.69% to $142.8 million in 2025.
  • Its EBT stands at $142.8 million for Q3 2025, versus $124.5 million for Q2 2025 and $118.2 million for Q1 2025.